amikacin has been researched along with Candidiasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kril, LM; Kwiatkowski, S; Nickell, JR; Shrestha, SK; Sviripa, VM; Watt, DS | 1 |
| Dimopoulou, D; Galanakis, E; Kofteridis, DP; Maraki, S; Ntaoukakis, M; Samonis, G; Sarchianaki, E; Spathopoulou, T | 1 |
| Chang, YL; Chen, JS; Hsu, HH; Hsueh, PR; Lee, YC | 1 |
| Anastassiadou, H; Dassiou, M; Samonis, G | 1 |
| Danisovicová, A; Drgona, L; Fuchsberger, P; Korec, S; Krcméry, V; Spánik, S; Svec, J | 1 |
| Daghistani, D; Horn, M; Rodriguez, Z; Schoenike, S; Toledano, S | 1 |
| Baranger, B; Brinquin, L; Fangio, P; Petitjeans, F; Rouquette-Vincenti, I; Szymczyszyn, P; Villevieille, T | 1 |
1 trial(s) available for amikacin and Candidiasis
| Article | Year |
|---|---|
Prevention of indwelling central venous catheter sepsis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Heparin; Humans; Incidence; Infant; Infection Control; Inservice Training; Male; Medical Staff, Hospital; Neoplasms; Nursing Staff, Hospital; Prospective Studies; Retrospective Studies; Sodium Chloride; Staphylococcal Infections; Vancomycin | 1996 |
6 other study(ies) available for amikacin and Candidiasis
| Article | Year |
|---|---|
Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Cell Line; Drug Discovery; Drug Resistance, Multiple; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Mycoses | 2017 |
Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Carbapenems; Disease Models, Animal; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Male; Mice | 2013 |
An esophageal mass with coexistent Mycobacterium chelonae and Candida albicans infections in an immunocompetent adult.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Fluconazole; Humans; Imipenem; Immunocompetence; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2006 |
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin | 1994 |
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
Topics: Amikacin; Antineoplastic Agents; Bacterial Infections; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Hearing; Humans; Kidney; Leukemia; Lymphoma; Neutropenia; Retrospective Studies | 1993 |
[Obesity, diabetes mellitus, and gas gangrene: a major therapeutic challenge].
Topics: Abscess; Amikacin; Anus Diseases; Buttocks; Candidiasis; Ceftazidime; Colostomy; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Fasciitis; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Hypertension; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Complications; Shock, Septic; Vancomycin | 2001 |